Whales with a lot of money to spend have taken a noticeably bearish stance on Illumina.
Looking at options history for Illumina ILMN we detected 16 trades.
If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with bullish expectations and 56% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $204,957 and 11, calls, for a total amount of $746,562.
What's The Price Target?
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $130.0 to $160.0 for Illumina over the recent three months.
Analyzing Volume & Open Interest
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Illumina's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Illumina's substantial trades, within a strike price spectrum from $130.0 to $160.0 over the preceding 30 days.
Illumina Option Activity Analysis: Last 30 Days
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ILMN | CALL | SWEEP | BULLISH | 10/18/24 | $13.5 | $12.3 | $13.5 | $135.00 | $144.4K | 940 | 304 |
| ILMN | CALL | SWEEP | BULLISH | 10/18/24 | $13.9 | $12.3 | $13.8 | $135.00 | $115.0K | 940 | 519 |
| ILMN | CALL | TRADE | BULLISH | 10/18/24 | $14.4 | $12.1 | $13.7 | $135.00 | $91.7K | 940 | 307 |
| ILMN | CALL | SWEEP | BEARISH | 10/18/24 | $13.5 | $13.4 | $13.4 | $135.00 | $84.9K | 940 | 193 |
| ILMN | CALL | TRADE | BULLISH | 10/18/24 | $14.2 | $12.2 | $13.8 | $135.00 | $84.1K | 940 | 436 |
About Illumina
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Having examined the options trading patterns of Illumina, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Where Is Illumina Standing Right Now?
- Trading volume stands at 1,002,732, with ILMN's price down by 0.0%, positioned at $149.07.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 20 days.
What Analysts Are Saying About Illumina
1 market experts have recently issued ratings for this stock, with a consensus target price of $252.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $252.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Illumina options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
